Penile atrophy from feminizing hormone therapy
Feminizing hormone therapy with estrogen plus androgen suppression can decrease penile size by inducing a castration-like reduction in androgen signaling within penile erectile tissue. Prolonged androgen deprivation promotes corporal tissue remodeling with smooth-muscle loss and extracellular matrix (ECM) deposition, producing fibrosis that is poorly reversible. [1–3]
Androgen-dependent maintenance of corporal structure
Penile erection depends on corporal smooth muscle content, endothelial integrity, and an intact trabecular architecture. Androgens support these anatomical and physiological substrates through direct cellular effects and through prevention of fibrosis. [1,2]
Tissue remodeling during androgen deprivation
Animal and mechanistic studies of androgen deprivation show penile corpus cavernosum remodeling characterized by:
- Decreased smooth muscle content in the corpora cavernosa. [1,2]
- Increased ECM deposition and disorganization of tissue structure. [1]
- Cellular changes that favor remodeling pathways associated with fibrosis and impaired corporal function. [1,2]
Fibrosis and scar formation as a mechanism of nonreversibility
Penile fibrosis represents replacement of functional smooth muscle cells with fibrotic tissue. Fibrosis creates a structural barrier to restoring normal corporal compliance and the normal smooth-muscle-to-ECM balance required for full erectile tissue expansion. [2,3]
Veno-occlusive and mechanical failure pathways
Androgen deprivation–associated loss of corporal smooth muscle and remodeling can precede venous outflow/veno-occlusive dysfunction pathways that impair erection physiology. These changes can persist because they reflect structural remodeling rather than only a transient hormone-driven functional shift. [1,2]
Time course and cumulative injury
Corporal remodeling processes begin early after androgen removal in experimental models. Continued remodeling over time increases the probability of established fibrotic architecture, which reduces the likelihood of restoration of baseline size and function after hormone reversal. [1]
Reversal limits even after androgen restoration
Reviews of penile fibrosis describe that restoration of hormonal signaling may not fully reverse established fibrosis because the dominant abnormality becomes scar-like structural change rather than reversible receptor-level suppression. Evidence discussed in these reviews supports that prevention of the fibrotic transition is more effective than reversal after fibrosis is established. [1,3]
Clinical implication for feminizing hormone therapy
With feminizing hormone therapy, the same androgen-suppressed state that drives penile atrophy can therefore produce changes that behave as “irreversible” at the tissue level once fibrosis and smooth-muscle depletion have occurred. [1–3]